bioAffinity named a finalist in the Lyfebulb Helsinn 2019 Innovation Summit in Oncology

Mar 6, 2019 | News

BioAffinity Technologies is proud to be named a finalist in the Lyfebulb Helsinn 2019 Innovation Summit in Oncology.

Lyfebulb-Helsinn Innovation Summit
March 18 and 19, 2019
Monaco,  Principality of Monaco

Ten finalists will compete at the second annual Lyfebulb-Helsinn Innovation Summit. The second annual Lyfebulb-Helsinn Innovation Award will be presented to an exceptional innovator with outstanding entrepreneurial potential to commercialize creative ideas to better manage cancer using drugs, medical devices or healthcare information technology

 

Categories

Recent Posts

Learn About CyPath Lung

CyPath Lung Test